21 CFR 58.15
§ 58.15 Inspection of a testing facility.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 58.15, § 58.15 Inspection of a testing facility, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/83502
- Permanent ID
ys:prov:83502@1- SHA-256
e6da643e52f5938730ed650abd79737239e175d1218f0707be58447323baa8c6
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) A testing facility shall permit an authorized employee of the Food and Drug Administration, at reasonable times and in a reasonable manner, to inspect the facility and to inspect (and in the case of records also to copy) all records and specimens required to be maintained regarding studies within the scope of this part. The records inspection and copying requirements shall not apply to quality assurance unit records of findings and problems, or to actions recommended and taken.
(b) The Food and Drug Administration will not consider a nonclinical laboratory study in support of an application for a research or marketing permit if the testing facility refuses to permit inspection. The determination that a nonclinical laboratory study will not be considered in support of an application for a research or marketing permit does not, however, relieve the applicant for such a permit of any obligation under any applicable statute or regulation to submit the results of the study to the Food and Drug Administration.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.